Publications
-
Changes in insulin resistance after initiation of raltegravir or protease inhibitors with
Citation: Dirajlal-Fargo, S, Moser C, Brown TT, Currier JS, Kelesidis T, Dube MP, Stein JH, Ribaudo HJ, McComsey GA. Changes in insulin resistance after initiation of raltegravir or protease inhibitors with tenofovir-emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infect Dis. 2016 Aug 29;3(3):ofw174. eCollection 2016 Sep. PMID: 27704026. PMCID: PMC5047417.
Date: 08/29/2016
Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared
Citation: Chan ES, Mirmonsef P, Brown TT, Landay AL, Klingman K, Ofotokun I, Weitzmann, Ribaudo HJ, Taiwo B. Differential CD4+ cell count increase and CD4+ : CD8+ ratio normalization with maraviroc compared with tenofovir. AIDS. 2016 Aug 24;30(13):2091-7. doi: 10.1097/QAD.0000000000001181. PMID: 27281061. PMCID: PMC4966543.
Date: 08/24/2016
Long-term bone mineral density changes in antiretroviral-treated HIV-infected individuals
Citation: Grant PM, Kitch D, McComsey GA, Collier A, Koletar S, Erlandson KM, Yin MT, Bartali B, Ha B, Melbourne K, Brown TT. Long-term bone mineral density changes in antiretroviral-treated HIV-infected individuals. J Infect Dis. 2016 Aug 15;214(4):607-11. doi: 10.1093/infdis/jiw204. Epub 2016 Jun 20. PMID: 27330053. PMCID: PMC4957444.
Date: 08/15/2016
The effect of chloroquine on immune activation and interferon signatures associated with HIV-1
Citation: Jacobson JM, Bosinger S, Kang M, Belaunzaran P, Matining RM, Wilson CC, Flexner C, Clagett B, Plants J, Klingman K, Purdue L, Janik J, Boone L, Deeks S, Douek D, Silvestri G, Landay AL, Lederman MM, ACTG A5258 Protocol Team. The effect of chloroquine on immune activation and interferon signatures associated with HIV-1. AIDS Res Hum Retroviruses. 2016 Jul;32(7):636-47. doi: 10.1089/AID.2015.0336. Epub 2016 Apr 19. PMID: 26935044. PMCID: PMC4931767.
Date: 07/15/2016
Epidemiological impact of achieving UNAIDS 90-90-90 targets for HIV care in India: a modelling study
Citation: Maddali MV, Gupta A, Shah M. Epidemiological impact of achieving UNAIDS 90-90-90 targets for HIV care in India: a modelling study epidemiological impact of achieving UNAIDS 90-90-90 targets for HIV care in India: a modelling study. BMJ Open. 2016 Jul 7;6(7):e011914. doi: 10.1136/bmjopen-2016-011914. PMID: 27388363 PMCID. PMC4947804.
Date: 07/07/2016
Phenotypic coreceptor tropism in perinatally HIV-infected youth failing antiretroviral therapy
Citation: Agwu AL, Yao TJ, Eshleman SH, Patel K, Huang W, Burchett SK, Siberry GK, Van Dyke RB; Pediatric HIVAIDS Cohort Study. Phenotypic coreceptor tropism in perinatally HIV-infected youth failing antiretroviral therapy. Pediatr Infect Dis J. 2016 Jul;35(7):777-81. doi: 10.1097/INF.0000000000001158. PMID: 27078121; PMCID: PMC4988058
Date: 07/01/2016
Quantitative IFN-γ and IL-2 response associated with latent tuberculosis test discordance in
Citation: Mathad JS, Bhosale R, Balasubramanian U, Kanade S, Mave V, Suryavanshi N, Gupte N, Joshi S, Chandanwale A, Dupnik KM, Kulkarni V, Deshpande P, Fitzgerald DW, Gupta A. Quantitative IFN-γ and IL-2 response associated with latent tuberculosis test discordance in HIV-infected pregnant women. Am J Respir Crit Care Med. 2016 Jun 15;193(12):1421-8. doi: 10.1164/rccm.201508-1595OC. PMID: 26765255 PMCID. PMC4910889.
Date: 06/15/2016
Isoniazid hair concentrations in children with tuberculosis: a proof of concept study
Citation: Mave V, Chandanwale A, Kinikar A, Khadse S, Kagal A, Gupte N, Suryavanshi N, Nimkar S, Koli H, Khwaja S, Bharadwaj R, Joshi S, Horng H, Benet LZ, Ramachandran G, Dooley KE, Gupta A, Gandhi M. Isoniazid hair concentrations in children with tuberculosis: a proof of concept study. Int J Tuberc Lung Dis. 2016 Jun;20(6):844-7. doi: 10.5588/ijtld.15.0882. PMID: 27155191. PMCID: PMC4889729.
Date: 06/15/2016
Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings:
Citation: Castillo-Mancilla JR, Aquilante CL, Wempe MF, Smeaton LM, Firnhaber C, LaRosa AM, Kumarasamy N, Andrade A, Baheti G, Fletcher CV, Campbell TB, Haas DW, MaWhinney S, Anderson PL. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). J Antimicrob Chemother. 2016 Jun;71(6):1609-18. doi: 10.1093/jac/dkw005. Epub 2016 Feb 17. PMID: 26892777. PMCID: PMC4867099.
Date: 06/15/2016
Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and
Citation: Hennig S, Svensson EM, Niebecker R, Fourie PB, Weiner MH, Bonora S, Peloquin CA, Gallicano K, Flexner C, Pym A, Vis P, Olliaro PL, McIlleron H, Karlsson M. Population pharmacokinetic drug-drug interaction pooled analysis of existing data for rifabutin and HIV PIs. J Antimicrob Chemother. 2016 May;71(5):1330-40. doi: 10.1093/jac/dkv470. Epub 2016 Jan 31. PMID: 26832753. PMCID: PMC4830412.
Date: 05/15/2016
- ‹ First < 11 12 13 14 15 > Last ›